Valeo Financial Advisors, LLC Ardelyx, Inc. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$3.29 - $6.64 $7,896 - $15,936	-2,400 Reduced 14.95%	13,650 $84,000
Q2 2023 Jul 14, 2023	SELL	$3.23 - $4.95 $59,432 - $91,080	-18,400 Reduced 53.41%	16,050 $54,000
Q1 2023 Apr 17, 2023	BUY	$2.68 - $4.79 $14,338 - $25,626	5,350 Added 18.38%	34,450 $165,000
Q4 2022 Feb 09, 2023	BUY	$1.22 - $2.85 $35,502 - $82,935	29,100 New	29,100 $82,000
Q4 2018 Jan 30, 2019	SELL	$1.66 - $4.16 $1,162 - $2,912	-700 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $2,590 - $4,060	700 New	700 $3,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.